Literature DB >> 9108525

Use of baculovirus expression vectors.

D R O'Reilly1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9108525     DOI： 10.1385/0-89603-480-1:235

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  6 in total

1.  Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus.

Authors:  W E Delaney; R Edwards; D Colledge; T Shaw; J Torresi; T G Miller; H C Isom; C T Bock; M P Manns; C Trautwein; S Locarnini
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Structure and Regulation of the Movement of Human Myosin VIIA.

Authors:  Tsuyoshi Sakai; Hyun Suk Jung; Osamu Sato; Masafumi D Yamada; Dong-Ju You; Reiko Ikebe; Mitsuo Ikebe
Journal:  J Biol Chem       Date:  2015-05-22       Impact factor: 5.157

3.  Construction of a highly efficient display system for baculovirus and its application on multigene co-display.

Authors:  Hao Zheng; Xiong Wang; Feifei Ren; Shenglong Zou; Min Feng; Liangliang Xu; Lunguang Yao; Jingchen Sun
Journal:  Mol Genet Genomics       Date:  2018-06-19       Impact factor: 3.291

4.  In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication.

Authors:  Richard A Heipertz; Thomas G Miller; Colleen M Kelley; William E Delaney; Stephen A Locarnini; Harriet C Isom
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

5.  Kinetic analysis of wild-type and YMDD mutant hepatitis B virus polymerases and effects of deoxyribonucleotide concentrations on polymerase activity.

Authors:  Richard K Gaillard; Jennifer Barnard; Vincent Lopez; Paula Hodges; Eric Bourne; Lance Johnson; Marchelle I Allen; Patrick Condreay; Wayne H Miller; Lynn D Condreay
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

6.  Hepatitis B virus (HBV)-specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular (CCC) DNA but has no effect on established CCC DNA in vitro.

Authors:  Jason L Starkey; Estelle F Chiari; Harriet C Isom
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.